He spent six years taking classes at UC Santa Barbara in the 1960s, but never intended to get a degree as he was focused on finding ways to make money, he recently told The Wall Street Journal.
His net worth has soared thanks to his more than 550 million shares of Summit, a roughly 75% stake. The company's stock price has surged by over 1,100% in the past 12 months.
Duggan's remarkable rise from a cookie business to biotech billionaire underscores that success can come in many forms, defying traditional educational paths.
While most biotech leaders typically have advanced degrees to decode complex medical research, Duggan navigates the industry with his unique entrepreneurial experience.
[
Collection
]
[
|
...
]